Sustained clinical and histopathological remission in a patient with
eosinophilic esophagitis and type 2 comorbidities after 18 months of
discontinuation of dupilumab
- Victor Gonzalez Uribe
, - Carlos Acosta Rodríguez-Bueno,
- Zaira Mojica-González,
- Andrea Malagón-Liceaga
, - Martín Basile-Alvarez
![](https://d197for5662m48.cloudfront.net/assets/icons/omniauth/orcid-ca37582cd91a671ed5cec57770e0e96c01b4b79b8b5b75d8598fc1ddac18c974.svg)
Victor Gonzalez Uribe
![](https://d197for5662m48.cloudfront.net/assets/icons/omniauth/orcid-ca37582cd91a671ed5cec57770e0e96c01b4b79b8b5b75d8598fc1ddac18c974.svg)
Universidad La Salle Facultad Mexicana de Medicina
Author ProfileCarlos Acosta Rodríguez-Bueno
Hospital Infantil de Mexico Federico Gomez
Author ProfileAndrea Malagón-Liceaga
![](https://d197for5662m48.cloudfront.net/assets/icons/omniauth/orcid-ca37582cd91a671ed5cec57770e0e96c01b4b79b8b5b75d8598fc1ddac18c974.svg)
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
Author Profile